Traders should note the significant premium offered and high likelihood of deal completion given the unanimous board support and lack of competing bids at closing price. The stock is likely to trade near the $231 offer price pending shareholder and regulatory approvals. Monitor for any developments on regulatory clearance, particularly from antitrust authorities in the U.S. and China.
Price Chart
Executive Summary
Silicon Laboratories (SLAB) is being acquired by Texas Instruments (TXN) in an all-cash deal valued at $231.00 per share, representing a 61% premium to the unaffected stock price. The transaction, expected to close in the first half of 2027, has been unanimously recommended by Silicon Labs' board and includes customary regulatory and shareholder approval conditions. Shareholders will vote on the merger at a special meeting on April 30, 2026.
Key Financial Metrics
Key Facts
- Texas Instruments is acquiring Silicon Laboratories for $231.00 per share in cash
- The deal represents a 61% premium to the 30-day volume-weighted average price and to the closing price on February 2, 2026
- The board of directors of Silicon Labs unanimously approved the transaction and recommended shareholder approval
- The merger consideration will be paid in cash, making SLAB a wholly-owned subsidiary of Texas Instruments
- Shareholders will vote on the merger at a special meeting on April 30, 2026, with approval requiring a majority of outstanding shares
- The transaction is subject to regulatory approvals including HSR Act clearance, with initial waiting period expiring April 20, 2026
- The deal is expected to close in the first half of 2027, assuming timely receipt of approvals and satisfaction of closing conditions
- Qatalyst Partners provided a fairness opinion that the merger consideration is fair from a financial point of view to Silicon Labs shareholders
Financial Impact
Total deal value of approximately $7.6 billion based on 32.97 million shares outstanding at $231 per share
Risk Factors
- Regulatory approval risk, particularly from antitrust authorities in the U.S. (DOJ/FTC) and China
- Risk of competing bids emerging before closing, though unlikely given Texas Instruments' superior offer
- Potential delays in closing beyond the first half of 2027 if regulatory approvals take longer than expected
- Deal could be terminated if conditions are not satisfied, including shareholder approval
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 2 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFM14A Filing (Primary) | 0001193125-26-128959 |
| Document: d34834ddefm14a.htm | 0001193125-26-128959 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 15, 2026 17d ago | Press Release | $219.71 $221.25 | ▲ +0.70% | ▼ −1.12% | $222.76 (+1.39%) |
Sep 4, 2026 28d ago | Press Release | $220.58 $219.28 | ▼ −0.59% | ▲ +0.62% | $222.76 (+0.99%) |
Aug 11, 2026 7w ago | Press Release | $218.83 $218.92 | ▲ +0.04% | ▲ +0.49% | $222.76 (+1.80%) |
May 26, 2026 18w ago | 8-K | $219.05 $218.75 | ▼ −0.14% | ▼ −1.35% | $222.76 (+1.69%) |
Mar 27, 2026 27w ago | DEFM14A | $205.85 $210.00 | ▲ +2.02% | ▼ −2.28% | $222.76 (+8.21%) |
Mar 25, 2026 27w ago | DEFA14A | $206.79 $209.13 | ▲ +1.13% | ▼ −0.50% | $222.76 (+7.72%) |
Mar 13, 2026 28w ago | PREM14A | $204.68 $206.96 | ▲ +1.11% | ▲ +3.16% | $222.76 (+8.83%) |
Mar 3, 2026 30w ago | DEFA14A | $203.58 $201.70 | ▼ −0.92% | ▲ +0.41% | $222.76 (+9.42%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access